• Privacy Policy
  • Terms and Conditions
  • Contact
Monday, October 19, 2026
Pharma Info Nepal
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
    • Pharmacy Act and Guidelines
    • Study Materials
  • Pharmacy Notes
    • B Pharmacy
    • D Pharmacy
No Result
View All Result
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
    • Pharmacy Act and Guidelines
    • Study Materials
  • Pharmacy Notes
    • B Pharmacy
    • D Pharmacy
No Result
View All Result
Pharma Info Nepal
No Result
View All Result
Home Pharmacy Notes

Classification of Beta-Blockers

Classification of Beta-Blockers

Pharma Info Nepal by Pharma Info Nepal
October 19, 2026
in Pharmacy Notes, Study Materials
0
Classification of Beta-Blockers
40
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Classification of Beta-Blockers

Classification of Beta-Blockers: Types, Examples, and Uses

Beta-blockers, also known as β-adrenergic receptor blockers, are drugs that block the effects of catecholamines, particularly adrenaline and noradrenaline, at beta-adrenergic receptors. They are widely used in the treatment of hypertension, angina pectoris, cardiac arrhythmias, heart failure, and other cardiovascular conditions.

Beta-blockers can be classified according to receptor selectivity, intrinsic sympathomimetic activity, additional vasodilating properties, and duration of action.


Classification of Beta-Blockers

ADVERTISEMENT

1. Classification Based on Beta-Receptor Selectivity

A. Non-selective beta-blockers

These drugs block both β₁ and β₂ adrenergic receptors.

Examples:

  • Propranolol
  • Nadolol
  • Timolol
  • Pindolol
  • Sotalol

Uses: Hypertension, angina, certain arrhythmias, glaucoma (timolol), and other specific indications.

B. Cardioselective beta-blockers (β₁-selective)

These drugs preferentially block β₁ receptors, which are mainly present in the heart. Their selectivity decreases at higher doses.

Examples:

  • Atenolol
  • Metoprolol
  • Bisoprolol
  • Esmolol
  • Betaxolol
  • Nebivolol

Uses: Hypertension, angina, selected arrhythmias, and chronic heart failure with specific agents such as bisoprolol and metoprolol succinate.

2. Classification Based on Intrinsic Sympathomimetic Activity (ISA)

Intrinsic sympathomimetic activity refers to the ability of a beta-blocker to produce partial stimulation of beta receptors while preventing stronger stimulation by endogenous catecholamines.

A. Beta-blockers with ISA

Examples:

  • Pindolol
  • Acebutolol
  • Oxprenolol
  • Celiprolol

B. Beta-blockers without ISA

Examples:

  • Propranolol
  • Atenolol
  • Metoprolol
  • Bisoprolol
  • Timolol
  • Nadolol

Exam point: Pindolol is a classic example of a beta-blocker with intrinsic sympathomimetic activity.

3. Classification Based on Additional Vasodilating Properties

A. Beta-blockers without prominent additional vasodilating action

Examples:

  • Propranolol
  • Atenolol
  • Metoprolol
  • Bisoprolol
  • Nadolol

B. Beta-blockers with additional vasodilating properties

Examples:

  • Carvedilol — blocks β₁, β₂, and α₁ receptors.
  • Labetalol — blocks α₁ and β receptors.
  • Nebivolol — promotes nitric oxide-mediated vasodilation.
  • Celiprolol — has β₁-blocking and β₂-agonist properties.

Exam point: Carvedilol and labetalol are important examples of beta-blockers that also block alpha-1 receptors.

4. Classification Based on Duration of Action

Duration varies with dose, formulation, route of administration, and individual patient factors. The following groups are approximate rather than universally standardized.

Duration Examples Important information
Ultra-short-acting Esmolol IV drug; half-life approximately 9 minutes
Short-acting Propranolol, immediate-release Half-life approximately 3–6 hours
Intermediate-acting Metoprolol, immediate-release Half-life approximately 3–7 hours
Longer-acting Atenolol Half-life approximately 6–9 hours; effects can last around 24 hours
Long-acting Nadolol Half-life approximately 20–24 hours
Long-acting Betaxolol Half-life approximately 14–22 hours
Long-acting Bisoprolol Half-life approximately 10–12 hours

 

5. Classification Based on Additional Pharmacological Properties

Property Examples
β₁-selective blockers Atenolol, metoprolol, bisoprolol
Non-selective blockers Propranolol, nadolol, timolol
Alpha-1 and beta blockers Carvedilol, labetalol
Beta-blockers with ISA Pindolol, acebutolol
Beta-blocker with nitric oxide-mediated vasodilation Nebivolol
Beta-blocker with potassium-channel-blocking antiarrhythmic activity Sotalol

6. Therapeutic Uses of Beta-Blockers

Beta-blockers are used in several clinical conditions:

  1. Hypertension: Selected beta-blockers help reduce blood pressure.
  2. Angina pectoris: Reduce heart rate and myocardial oxygen demand.
  3. Cardiac arrhythmias: Help control heart rate in selected tachyarrhythmias.
  4. Heart failure: Bisoprolol, carvedilol, and sustained-release metoprolol succinate improve outcomes in appropriate patients with heart failure with reduced ejection fraction.
  5. Post-myocardial infarction: Used in selected patients according to clinical indication.
  6. Glaucoma: Timolol reduces aqueous humour production and intraocular pressure.
  7. Hyperthyroidism: Propranolol helps control symptoms such as tremor and tachycardia.
  8. Migraine prophylaxis: Propranolol and selected other beta-blockers may be used to prevent migraine.
  9. Essential tremor: Propranolol is a commonly used option.

7. Important Adverse Effects and Precautions

Common adverse effects include:

  • Bradycardia
  • Hypotension
  • Fatigue
  • Dizziness
  • Exercise intolerance
  • Sexual dysfunction in some patients

Important precautions:

  • Non-selective beta-blockers may cause bronchospasm, particularly in patients with asthma.
  • Beta-blockers may mask some symptoms of hypoglycaemia, especially tachycardia.
  • Abrupt discontinuation can cause rebound tachycardia, worsening angina, or other cardiovascular complications.
  • They should be used according to the patient’s condition and clinical guidance.

8. Important MCQ Points for Pharmacy and Loksewa Exams

  1. Ultra-short-acting beta-blocker: Esmolol.
  2. Non-selective beta-blocker: Propranolol.
  3. Cardioselective beta-blocker: Atenolol.
  4. Beta-blocker with ISA: Pindolol.
  5. Beta-blocker with alpha-1-blocking activity: Carvedilol.
  6. Beta-blocker used in glaucoma: Timolol.
  7. Beta-blocker with nitric oxide-mediated vasodilating activity: Nebivolol.
  8. Beta-blocker with potassium-channel-blocking activity: Sotalol.
  9. Beta-blockers commonly used in heart failure with reduced ejection fraction: Bisoprolol, carvedilol, and metoprolol succinate.

Beta-blockers are an important class of cardiovascular drugs. Their classification according to receptor selectivity, ISA, vasodilating properties, and duration of action helps students understand their pharmacological differences and clinical uses. For pharmacy licensing and Loksewa examinations, focus particularly on propranolol, atenolol, metoprolol, esmolol, pindolol, carvedilol, labetalol, nebivolol, timolol, and sotalol.

 



  • Classification of Antihypertensive Drugs
  • Classification of Anti-Cancer Drugs
Tags: Classification of Beta-BlockersStudy Materials
Previous Post

B Pharmacy College-Wise Seat Distribution in Nepal 2083: 29 Colleges, 905 Seats

Pharma Info Nepal

Pharma Info Nepal

Pharma Info Nepal is Nepal's leading pharmacy education and information platform, dedicated to pharmacists, pharmacy students, and healthcare professionals. We provide trusted pharmacy news, regulatory updates, NPC and Loksewa exam resources, verified job opportunities, scholarships, research insights, and professional guidance to support excellence in pharmacy practice and education.

Related Posts

Pharma Info App — Your Pharmacy Exam Preparation Platform
Study Materials

Pharma Info App — Your Pharmacy Exam Preparation Platform

September 27, 2026
Classification of Anti-Cancer Drugs
Study Materials

Classification of Anti-Cancer Drugs

August 3, 2026
Classification of Antihypertensive Drugs
Study Materials

Classification of Antihypertensive Drugs

October 18, 2026
Good Manufacturing Practice (GMP) and Elements of GMP
B Pharmacy

Good Manufacturing Practice (GMP) and Elements of GMP

July 29, 2026
Load More

Recommended

Classification of Beta-Blockers

Classification of Beta-Blockers

October 19, 2026
B Pharmacy College-Wise Seat Distribution in Nepal 2083: 29 Colleges, 925 Seats

B Pharmacy College-Wise Seat Distribution in Nepal 2083: 29 Colleges, 905 Seats

October 18, 2026
Vacancy Announcement for Pharmacy Officer and Pharmacy Assistant

Vacancy Announcement for Pharmacy Officer and Pharmacy Assistant

October 17, 2026
Nepal Pharmacy Council 32nd Name Registration Examination 2083 Online Application Form Notice

Nepal Pharmacy Council 32nd Name Registration Examination 2083 Online Application Form Notice

October 19, 2026
Vacancy Announcement Pharmacy Assistant TU Teaching Hospital

Vacancy Announcement Pharmacy Assistant TU Teaching Hospital

October 4, 2026
ADVERTISEMENT
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

About Pharma Info Nepal

Pharma Info Nepal is a dedicated platform led by Nabin Bista, focused on empowering pharmacy students and professionals in Nepal. We provide high-quality educational resources, exam preparation materials, and professional guidance for pharmacy licensure exams and beyond. Our mission is to uplift the pharmacy profession in Nepal by fostering knowledge, skills, and excellence in pharmaceutical practice.

Explore our services, stay updated on pharmacy trends, and join a community striving for innovation and professionalism in healthcare.

IMPORTANT INFORMATION

All content available on this website, including text, images, files, and other resources, is strictly protected under applicable copyright and intellectual property laws. Any reuse, reproduction, or redistribution of materials without prior written permission from Pharma Info Nepal is prohibited and may result in legal action.

Pharma Info Nepal operates as a registered company dedicated to maintaining the authenticity and integrity of its content and services.

Thank you for respecting our policies and supporting our mission to advance pharmacy education and practice.

CATEGORIES

  • B Pharmacy
  • Colleges
  • D Pharmacy
  • Downloads
  • License
  • Loksewa
  • M Pharmacy
  • Medicinal Chemistry
  • Notice
  • Nursing
  • Pharmacognosy
  • Pharmacology
  • Pharmacy Notes
  • Questions
  • Scholarship
  • Study Materials
  • Syllabus
  • Updates
  • Vacancy
  • Home
  • Vacancy
  • Courses
  • License
  • Loksewa
  • Questions
  • Downloads
  • Pharmacy Books
  • Pharmacy Notes

© 2026 Pharma Info Nepal Pvt. Ltd | All Rights Reserved

error:
No Result
View All Result
  • Home
  • Courses
  • Questions
  • Downloads
  • About Pharma Info Nepal 

© 2026 Pharma Info Nepal Pvt. Ltd | All Rights Reserved